June 08, 2021
Pointing to uncertainty around Mallinckrodt ARD LLC's pending bankruptcy proceedings in Delaware, the U.S. Judicial Panel on Multidistrict Litigation deemed it "premature" on Monday to centralize a string of antitrust cases over the company's sales of the anti-seizure drug Acthar.
May 27, 2021
A member of the Judicial Panel on Multidistrict Litigation on Thursday questioned Mallinckrodt ARD LLC's push to have a battery of antitrust cases over sales of the anti-seizure drug Acthar transferred to federal court in Delaware where the company is currently making its way through bankruptcy proceedings.